Skip to content
Screener

Regeneron Pharmaceuticals REGN Q1 2025 earnings

Reported April 29, 2025 · Before market open

Revenue$3.0BMiss by $219.3M
EPS$8.22Miss by $0.40
Revenue estimate$3.2B
EPS estimate$8.62

Next report

Oct 30, 2026 (In 3 weeks)
Revenue estimate$4.5B
EPS estimate$15.99

Financials

Q1 2025

Income statement

See full
Revenue$3.0B-3.7%
Operating income$591.7M-21.3%
Net income$808.7M+12.0%
EPS (diluted)$7.27+15.9%

Balance sheet

See full
Cash & equivalents$3.1B+18.5%
Total debt$2.7B+0.1%
Total equity$29.4B+8.9%
Total assets$37.5B+9.2%

Cash flow

See full
Operating cash flow$1.0B-30.9%
CapEx$229.3M+71.2%
Free cash flow$815.8M-40.8%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$69.34B-33.2%
Enterprise value$68.95B-33.6%
P/E15.4×-11.5×
P/S4.9×-3.0×

Profitability

See full
Operating margin27.2%-2.2pp
Net margin31.9%+2.5pp
FCF margin22%-9.0pp

Returns & leverage

See full
Return on equity16%+0.7pp
Debt / equity0.1×0.0×
Current ratio4.9×-0.3×

Segments

By product

See full
Reimbursement For Manufacturing Of Commercial Supplies$165.0M—
Reimbursement Of Commercialization Related Expenses$159.2M—
(Regeneron's obligation for its share of Sanofi R&D expenses)/reimbursements of R&D expenses, net-$15.5M—

FAQ

When did Regeneron Pharmaceuticals report Q1 2025 earnings?
Regeneron Pharmaceuticals (REGN) reported Q1 2025 earnings on April 29, 2025 before market open.
What were Regeneron Pharmaceuticals's Q1 2025 revenue and EPS?
Regeneron Pharmaceuticals reported revenue of $3.0B and eps of $8.22 for Q1 2025.
Did Regeneron Pharmaceuticals beat estimates in Q1 2025?
Revenue missed the consensus estimate of $3.2B by $219.3M. EPS missed the consensus estimate of $8.62 by $0.40.
How did Regeneron Pharmaceuticals's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 3.7% from $3.1B a year earlier and eps declined 13.9% from $9.55.
Where can I find Regeneron Pharmaceuticals's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001804220-25-000020) and the 10-Q periodic report (0001804220-25-000022) directly on SEC EDGAR. The filing index links above go to sec.gov.